GLP-1 Weight Loss for Prediabetes
Prediabetes affects a staggering 96 million American adults -- more than 1 in 3 -- yet over 80% of those affected don't know they have it. Prediabetes means your blood sugar levels are elevated above normal but not yet high enough for a type 2 diabetes diagnosis. Without intervention, approximately 15-30% of people with prediabetes will develop type 2 diabetes within 5 years. The primary driver is insulin resistance, often caused by excess body weight, particularly visceral fat. Prediabetes is a critical window of opportunity: it is the stage where type 2 diabetes is still preventable.
GLP-1 treatment for patients with Prediabetes. Prescribed by licensed providers, delivered to your door. Compounded medications are not FDA-approved.
From 2,000+ patients · Prediabetes is already seeing results
Semaglutide and tirzepatide are the active ingredients in FDA-approved GLP-1 medications (Wegovy®, Zepbound®) whose clinical trials of the FDA-approved brand-name products studied populations that included patients with Prediabetes. Prediabetes affects approximately 96 million US adults have prediabetes of U.S. adults. Weight Method offers compounded programs starting at $199/month with virtual consultations and direct shipping. Compounded medications are not FDA-approved.
How do GLP-1 medications help with this condition?
GLP-1 receptor agonists are powerful tools for diabetes prevention because they directly improve insulin sensitivity while driving significant weight loss. The landmark Diabetes Prevention Program showed that losing just 5-7% of body weight reduces diabetes risk by 58%. GLP-1 medications like semaglutide and tirzepatide typically produce weight loss of 15-20%, far exceeding this threshold. These medications also improve pancreatic beta-cell function, helping your body produce and use insulin more efficiently. For people with prediabetes, GLP-1 therapy is one pharmacological option that may help reduce the risk of progression to type 2 diabetes.
Who qualifies for treatment?
If you have prediabetes (fasting glucose 100-125 mg/dL or HbA1c 5.7-6.4%) and a BMI of 27 or higher, GLP-1 therapy is strongly indicated. Even without a formal prediabetes diagnosis, elevated blood sugar combined with excess weight makes you a candidate for preventive treatment. Weight Method providers assess your metabolic risk and can help identify prediabetes during the evaluation process.
How It Works
Take the Quiz
Answer questions about your health and medical condition.
Virtual Consultation
A provider will review your case and create a personalized plan.
Get Your Medication
Your GLP-1 medication ships directly to your door.
Your Treatment Options
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.
